β‐Amyloid precursor protein is modified with O‐linked N‐acetylglucosamine
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
The β‐amyloid precursor protein (APP) has been implicated in the etiology of Alzheimer's disease (Kang et al.: Nature 325:733–736, 1987; Selkoe: Science 248:1058–1060, 1990; Selkoe: In Cowan et al. (eds): “Annual Review of Neuroscience.” Palo Alto, CA: Annual Reviews, Inc., pp 489–519, 1994) and numerous studies have shown that b̃‐amyloid is involved in amyloid plaque formation (Rumble et al.: N Engl J Med 320:1446–1452, 1989; Sisodia et al.: Science 248: 492–495, 1990). Evidence is presented that APP is modified with N‐acetylglucosamine linked to cytoplasmic serine or threonine residues (O‐GIcNAc). This is the first report of a plasma membrane protein modified with this carbohydrate. It has been postulated that this modification, which is ubiquitous in all organisms studied to date except bacteria (Haltiwanger et al.: Biochem Soc Trans 20:264–269, 1992; Dong et al.: J Biol Chem 268:16679–16687, 1993; Elliot et al.: J Neurosci 13:2424–2429, 1993; Kelly et al.: J Biol Chem 268:10416–10424, 1993), may function as an alternative to phosphorylation (Dong et al., 1993) and is involved in the multimerization of proteins (Haltiwanger et al., 1992; Dong et al., 1993). O‐GlcNAc occurs at “PEST” sequences (Rogers et al.: Science 234:364–368, 1986) and it has been suggested that this modification within such a sequence leads to increased proteolytic stability of the molecule (Dong et al., 1993). The importance of proteolytic cleavage (Kang et al., 1987; Selkoe, 1990, 1994), and the possible involvement of phosphorylation (Gandy et al.: Proc Natl Acad Sci USA 85:6218–6221, 1988; Gillespie et al.: Biochem Biophys Res Commun 187: 1285–1290, 1992; Suzuki et al.: J Neurosci 48:755–761, 1992; Suzuki et al.: EMBO J 13:1114–1122, 1994) in the regulation of APP processing suggest that this novel modification may somehow be involved in the biochemistry of APP. © 1995 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619 · cited 2×
“The importance of proteolytic cleavage (Kang et al., 1987; Selkoe, 1990, 1994), and the possible involvement of phosphorylation (Gandy et al.”
BackgroundAmyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Cited by
Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins
Hart, G. W., Housley, M. P., & Slawson, C. (2007) · Nature · doi:10.1038/nature05815 · Cited by 1,418
Hart, G. W., Slawson, C., Ramirez-Correa, G., & Lagerlof, O. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060608-102511 · Cited by 1,317
“Amyloid precursor proteins, whose degradation products form the neuronal plaques in the disease, are OGlcNAcylated in their cytosolic domain (200), which may affect their processing to the toxic Aβ peptides found in AD plaques.”
BackgroundShafi, R., Iyer, S. P. N., Ellies, L. G., O'Donnell, N., Marek, K. W., Chui, D., Hart, G. W., & Marth, J. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100471497 · Cited by 794
Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins
Gao, Y., Wells, L., Comer, F. I., Parker, G. J., & Hart, G. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010420200 · Cited by 761
Concepts and Principles of O-Linked Glycosylation
Steen, P. V. D., Rudd, P. M., Dwek, R. A., & Opdenakker, G. (1998) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409239891204198 · Cited by 760
DYNAMIC O-LINKED GLYCOSYLATION OF NUCLEAR AND CYTOSKELETAL PROTEINS
Hart, G. W. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.315 · Cited by 508
The Hexosamine Signaling Pathway: Deciphering the "O-GlcNAc Code"
Love, D. C., & Hanover, J. A. (2005) · Science's STKE · doi:10.1126/stke.3122005re13 · Cited by 461
ZACHARA, N. (2004) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2004.03.016 · Cited by 426
Common pathological processes in Alzheimer disease and type 2 diabetes: A review
Li, L., & Hölscher, C. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.09.001 · Cited by 367
The Microtubule-associated Protein Tau Is Extensively Modified with O-linked N-acetylglucosamine
Arnold, C. S., Johnson, G. W., Cole, R. N., Dong, D. L.-Y., Lee, M., & Hart, G. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.28741 · Cited by 361
O-Glycosylation of Nuclear and Cytosolic Proteins
Comer, F. I., & Hart, G. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000010200 · Cited by 361
Role of O-linked N-acetylglucosamine protein modification in cellular (patho)physiology
Chatham, J. C., Zhang, J., & Wende, A. R. (2021) · Physiological Reviews · doi:10.1152/physrev.00043.2019 · Cited by 352
Nutrient regulation of signaling and transcription
Hart, G. W. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.aw119.003226 · Cited by 345
The role of protein glycosylation in Alzheimer disease
Schedin‐Weiss, S., Winblad, B., & Tjernberg, L. O. (2014) · The FEBS Journal · doi:10.1111/febs.12590 · Cited by 317
Zeidan, Q., & Hart, G. W. (2010) · Journal of Cell Science · doi:10.1242/jcs.053678 · Cited by 298
The Emerging Significance of O-GlcNAc in Cellular Regulation
Zachara, N. E., & Hart, G. W. (2002) · Chemical Reviews · doi:10.1021/cr000406u · Cited by 284
Glycan-dependent signaling: O-linked N-acetylglucosamine
HANOVER, J. A. (2001) · The FASEB Journal · doi:10.1096/fj.01-0094rev · Cited by 283
The Emerging Link between O-GlcNAc and Alzheimer Disease
Zhu, Y., Shan, X., Yuzwa, S. A., & Vocadlo, D. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.601351 · Cited by 267
Kim, C., Nam, D. W., Park, S. Y., Song, H., Hong, H. S., Boo, J. H., Jung, E. S., Kim, Y., Baek, J. Y., Kim, K. S., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.03.001 · Cited by 121
Implications of Glycosylation in Alzheimer’s Disease
Haukedal, H., & Freude, K. K. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.625348 · Cited by 114
Pinho, T. S., Correia, S. C., Perry, G., Ambrósio, A. F., & Moreira, P. I. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.037 · Cited by 70
Exploration of O-GlcNAc transferase glycosylation sites reveals a target sequence compositional bias
(2023) · doi:10.1016/j.jbc.2023.104629 · Cited by 16
Metadata
- Authors
- Griffith, L. S., Mathes, M., & Schmitz, B.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 1995-06
- Volume
- 41
- Issue
- 2
- Pages
- 270-278
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W1998044291
- Cited by
- 154
- References
- 2
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.